Discontinued — last reported Q1 '24
HCA Healthcare Proceeds from lines of credit increased by 114.5% to $296.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Proceeds from lines of credit shows a downward trend with a -7.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High usage may signal short-term liquidity pressure, while low usage indicates strong internal cash generation.
This represents cash inflows specifically derived from drawing down on revolving credit facilities. It serves as a short...
Company-specific; peers use similar facilities, but reporting varies by disclosure level.
cf_amd_proceeds_from_lines_of_credit| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $720.00M | -$300.00M | $2.28B | -$2.78B | $3.71B | -$1.16B | $350.00M | $1.24B | -$3.08B | $420.00M | -$1.88B | $850.00M | -$850.00M | $0.00 | $220.00M | $1.55B | $138.00M | $296.00M |
| QoQ Change | — | -141.7% | +860.0% | -221.9% | +233.5% | -131.3% | +130.2% | +254.3% | -348.4% | +113.6% | -547.6% | +145.2% | -200.0% | +100.0% | — | +603.6% | -91.1% | +114.5% |
| YoY Change | — | — | — | — | +415.3% | -286.7% | -84.6% | +144.6% | -183.0% | +136.2% | -251.6% | +127.6% | -302.4% | — | +111.7% | +82.1% | +116.2% | — |